Literature DB >> 11904661

Hypoproteinemia as a marker of acute respiratory distress syndrome in critically ill patients with pulmonary edema.

Syafri K Arif1, Joanne Verheij, A B Johan Groeneveld, Pieter G H M Raijmakers.   

Abstract

OBJECTIVE: To assess the value of serum protein levels for differentiating permeability pulmonary edema in the course of acute respiratory distress syndrome (ARDS) from cardiogenic pulmonary edema (CPE). DESIGN AND
SETTING: Observational cohort study in intensive care units of 720-bed university hospital. PATIENTS: Twenty-four consecutive patients with clinical evidence of edema, 11 fulfilling the consensus definition of ARDS, 7 having sepsis, 5 with all ARDS consensus criteria and sepsis but a pulmonary capillary wedge pressure above 18 mmHg (mixed), and 8 with CPE. All patients except for one with CPE were mechanically ventilated. MEASUREMENTS AND
RESULTS: Radionuclide assessments of pulmonary microvascular protein (transferrin) permeability (pulmonary leak index, PLI) were carried out and serum protein levels determined at admission and for ARDS/mixed patients, at recovery, defined by a decrease in positive end-expiratory pressure to 0 cmH2O. At admission the PLI was higher in ARDS/mixed than in CPE patients. The total protein and transferrin levels were lower in the former. The area under the curve of the receiver operating characteristic for diagnosing ARDS (vs. CPE) was 0.98 for transferrin (cutoff value 1.5 g/l), 0.95 for total protein (cutoff value 59 g/l) and 0.80 for albumin (cutoff value 24 g/l) levels. In various clinical diagnostic groups the transferrin level approached the PLI in diagnostic value. At recovery the PLI had decreased and serum protein levels increased.
CONCLUSIONS: The data suggest that hypoproteinemia is a marker of ARDS. This may partially reflect increased permeability in the lungs, systemically, or both.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11904661     DOI: 10.1007/s00134-002-1220-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  7 in total

1.  Metabolic effects of albumin therapy in acute lung injury measured by proton nuclear magnetic resonance spectroscopy of plasma: a pilot study.

Authors:  Youngja Park; Dean P Jones; Thomas R Ziegler; Kichun Lee; Kavitha Kotha; Tianwei Yu; Greg S Martin
Journal:  Crit Care Med       Date:  2011-10       Impact factor: 7.598

Review 2.  Albumin: physiologic and clinical effects on lung function.

Authors:  C Polito; G S Martin
Journal:  Minerva Anestesiol       Date:  2013-06-25       Impact factor: 3.051

3.  Albumin rather than C-reactive protein may be valuable in predicting and monitoring the severity and course of acute respiratory distress syndrome in critically ill patients with or at risk for the syndrome after new onset fever.

Authors:  Sandra H Hoeboer; Heleen M Oudemans-van Straaten; A B Johan Groeneveld
Journal:  BMC Pulm Med       Date:  2015-03-14       Impact factor: 3.317

Review 4.  A systematic review of diagnostic methods to differentiate acute lung injury/acute respiratory distress syndrome from cardiogenic pulmonary edema.

Authors:  Kosaku Komiya; Tomohiro Akaba; Yuji Kozaki; Jun-Ichi Kadota; Bruce K Rubin
Journal:  Crit Care       Date:  2017-08-25       Impact factor: 9.097

Review 5.  Systematic review of diagnostic methods for acute respiratory distress syndrome.

Authors:  Laura A Hagens; Nanon F L Heijnen; Marry R Smit; Marcus J Schultz; Dennis C J J Bergmans; Ronny M Schnabel; Lieuwe D J Bos
Journal:  ERJ Open Res       Date:  2021-01-18

6.  Correlation of Serum Albumin Level to Lung Ultrasound Score and Its Role as Predictors of Outcome in Acute Respiratory Distress Syndrome Patients: A Prospective Observational Study.

Authors:  Souvik Chaudhuri; Sagar S Maddani; Shwethapriya Rao; Sirish Gauni; N R Arjun; Pratibha Todur; Nitin Gupta
Journal:  Crit Care Res Pract       Date:  2021-12-07

7.  Serum albumin and the short-term mortality in individuals with congestive heart failure in intensive care unit: an analysis of MIMIC.

Authors:  Peng Chao; Xinyue Cui; Shanshan Wang; Lei Zhang; Qingru Ma; Xueqin Zhang
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.